Form Type: 4

SEC EDGAR Link
Accession Number:0001179110-20-008891
Date:2020-08-07
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
Original Submission Date:

Reporting Person:

GLASS GEOFFREY MICHAEL
C/O AVADEL PHARMACEUTICALS PLC
BLOCK 10-1 BLANCHARDSTOWN CORP. PARK DUBLIN, L2 15

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 8.48 2020-08-07 deemed execution date A 42,000 (a) 2020-08-07 adss 42,000 $8.48 42,000 direct
Footnotes
IDfootnote
f1 options become exercisable as to 14,000 adss on each of the first three anniversaries after the 08/07/2020 grant date.
f2 the issuer's "adss" are american depositary shares, with each ads representing one ordinary share, nominal value $0.01 per share, of the issuer; adss may be represented by americandepositary receipts.
WhaleWisdom Logo

Elevate your investments